Non-coronary heart disease mortality and risk of fatal cancer in patients with treated heterozygous familial hypercholesterolaemia: a prospective registry study. by Neil, H, Hawkins, M, Durrington, P, Betteridge, D, Capps, N, Humphries, SE

Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study by Neil, A, Cooper, J, Betteridge, J, Capps, N, McDowell, I, Durrington, P, Seed, M, Humphries, S

Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study. by Neil, A, Cooper, J, Betteridge, J, Capps, N, McDowell, I, Durrington, P, Seed, M, Humphries, SE

This house believes that the UK healthcare system may be failing as many as 50% of patients with hyperlipidaemia by not reducing their cholesterol to effective levels: A debate by Weston, C, Capps, N, Findley, S, Foxton, J, Hobbs, R, McCormack, T, McMorran, J, Pittard, J, Procter-King, J

All-cause and cardiovascular mortality in treated patients with severe hypertriglyceridaemia: A long-term prospective registry study. by Neil, H, Cooper, J, Betteridge, D, Capps, N, McDowell, I, Durrington, P, Seed, M, Mann, J, Humphries, SE